The Food and Drug Administration approved Amgen’s Kyprolis for second-line treatments of multiple-myeloma on Friday. Thousand Oaks-based Amgen’s new treatment for multiple-myeloma could pay off big for the company now that the treatment can be accessed by more patients in the second line of treatments. Kyprolis was approved for third-line treatments in 2012. The FDA’s Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
East Ventura County has a major new employer. Deerfield, Ill.-based Baxalta Inc. was launched July 1 as health care giant Baxter International split into two companies. Former Baxter Bioscience operations in Thousand Oaks and Newbury Park are part of the Baxalta spinoff. The operations employed about 1,100 people in East Ventura County, according to the Read More →
Westlake Village-based Qualstar Corp., a manufacturer of data and archive storage solutions and high efficiency power supplies, released the Qualstar Q1 on Thursday. The Qualstar Q1 is a archive solution to transfer and archive data. Qualstar describes the product as a cost effective solution for people who want to restore archives or review data. The Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amid a startup wave in Santa Monica, a revitalizing downtown and an emerging tech corridor on Highway 101, a younger and hipper group of entrepreneurs is beginning to reshape the corporate culture of Greater Los Angeles. That’s part of the reason why it put a smile on my face to see two companies from Ventura Read More →
Just a few months after it shut a Santa Barbara facility, Botox-maker Allergan has re-entered the Tri-Counties, agreeing to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion. The deal will add the Westlake Village-based Kythera’s treatments for double chins and male pattern baldness to Allergan’s existing line of products, including a breast implant operation formerly Read More →
